Viral Response to Antiretroviral Therapy in a Patient Coinfected with HIV Type 1 and Type 2
Open Access
- 15 July 2005
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (2), e19-e21
- https://doi.org/10.1086/431204
Abstract
Clinical experience with the treatment of human immunodeficiency virus (HIV) type 2 (HIV-2) infection is limited, and even more scarce is informationKeywords
This publication has 21 references indexed in Scilit:
- Polymorphism of the Human Immunodeficiency Virus Type 2 (HIV-2) Protease Gene and Selection of Drug Resistance Mutations in HIV-2-Infected Patients Treated with Protease InhibitorsJournal of Clinical Microbiology, 2005
- High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimenJournal of Medical Virology, 2004
- Identification of a Highly Divergent HIV Type 2 and Proposal for a Change in HIV Type 2 ClassificationAIDS Research and Human Retroviruses, 2004
- Evaluation of an early intervention Tier 2 child and adolescent mental health serviceHealth & Social Care in the Community, 2004
- Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'IvoireAIDS, 2004
- Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral loadAIDS, 2004
- Antiretroviral therapy in HIV-2-infected patientsAIDS, 2003
- Plasma RNA Viral Load in Human Immunodeficiency Virus Type 2 Subtype A and Subtype B InfectionsJournal of Clinical Microbiology, 2002
- Protease Gene Analysis of HIV Type 1 Non-B Subtypes in SpainAIDS Research and Human Retroviruses, 2000
- Antiretroviral Therapy in Patients with Dual Infection with Human Immunodeficiency Virus Types 1 and 2New England Journal of Medicine, 2000